Parion Sciences, Inc.
Durham, NC
- UEI
- TL3MFHAS6QT9
- CAGE
- 50KB0
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 2800 Meridian Pkwy #195, Durham, NC 27713, USA
- Website
- parion.com
- Founded
- 2000
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 38 Instruments & Related Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| A novel enac blocker/osmolyte inhalation solution for the treatment of muco-obstructive lung diseases - abstract… | National Heart Lung and Blood Institute | $2,267,449 | |
| Novel dual acting antibiotics for pulmonary disease | National Institute of Allergy and Infectious Diseases | $274,173 | |
| Novel mucolytic agents | National Institutes of Health | $319,012 | |
| Hypertonic saline for cystic fibrosis | National Institutes of Health | $1,509,420 | |
| Hypertonic saline for cystic fibrosis | National Institutes of Health | $244,797 |
About Parion Sciences, Inc.
Parion Sciences, Inc. is a development-stage biopharmaceutical company specializing in the creation of innovative therapies for muco-obstructive lung diseases. Registered with SAM.gov since 2008, the company focuses on restoring lung mucosal surface defenses and developing novel treatments for conditions such as COPD, asthma, cystic fibrosis, and primary ciliary dyskinesia. Parion Sciences has received both prime and sub-grant awards from federal agencies to support its research and development efforts. The company's expertise lies in creating pharmaceutical solutions that target mucus-related respiratory conditions, with a particular emphasis on combination therapies and novel drug formulations designed to improve mucus clearance and lung function in patients with chronic respiratory diseases.
Through its federal grant awards, Parion Sciences has undertaken significant research projects aimed at advancing potential treatments for muco-obstructive lung diseases. A recent $295,700 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) supports the development of a novel combination therapy involving an ENaC blocker (P-1155) and an osmolyte for treating conditions like COPD and asthma. This project includes formulation studies, efficacy testing in animal models, aerosol delivery development, and toxicology studies, with the ultimate goal of filing an Investigational New Drug (IND) application for COPD treatment. Additionally, Parion has received funding from the National Institute of Allergy and Infectious Diseases (NIAID) for research on novel dual-acting antibiotics for pulmonary diseases. The company has also participated as a sub-awardee in a project led by the University of Colorado, focusing on MUC5B as a potential therapeutic target for Idiopathic Pulmonary Fibrosis (IPF). These diverse grant activities underscore Parion Sciences' commitment to advancing respiratory medicine through innovative research and development efforts supported by federal funding, particularly in the areas of mucus hydration, antibiotic development, and targeted therapies for specific respiratory conditions.
Quick answers
What is Parion Sciences, Inc.'s UEI?
Parion Sciences, Inc.'s Unique Entity ID (UEI) in SAM.gov is TL3MFHAS6QT9.
What is Parion Sciences, Inc.'s CAGE code?
Parion Sciences, Inc.'s CAGE code is 50KB0.
What is Parion Sciences, Inc.'s primary NAICS code?
Parion Sciences, Inc.'s primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).
Where is Parion Sciences, Inc. located?
Parion Sciences, Inc.'s physical address in SAM.gov is 2800 Meridian Pkwy #195, Durham, NC 27713, USA.
Is Parion Sciences, Inc. registered in SAM.gov?
Yes. Parion Sciences, Inc.'s SAM.gov registration is active through June 22, 2027.
What is Parion Sciences, Inc.'s most recent federal award?
Parion Sciences, Inc.'s most recent federal grant award is A novel enac blocker/osmolyte inhalation solution for the treatment of muco-obstructive lung diseases - abstract… (R44HL174235), from National Heart Lung and Blood Institute, on May 1, 2024.
On GovTribe
See Parion Sciences, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors